The DOI matches its Crossref record; 580 of the 580 references it cites were found in a registry or an index.
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Open accessAbstract
The mood stabilizers lithium and valproic acid (VPA) are traditionally used to treat bipolar disorder (BD), a severe mental illness arising from complex interactions between genes and environment that drive deficits in cellular plasticity and resiliency. The therapeutic potential of these drugs in other central nervous system diseases is also gaining support. This article reviews the various mechanisms of action of lithium and VPA gleaned from cellular and animal models of neurologic, neurodegenerative, and neuropsychiatric disorders. Clinical evidence is included when available to provide a comprehensive perspective of the field and to acknowledge some of the limitations of these treatments. First, the review describes how action at these drugs' primary targets--glycogen synthase kinase-3 for lithium and histone deacetylases for VPA--induces the transcription and expression of neurotrophic, angiogenic, and neuroprotective proteins. Cell survival signaling cascades, oxidative stress pathways, and protein quality control mechanisms may further underlie lithium and VPA's beneficial actions. The ability of cotreatment to augment neuroprotection and enhance stem cell homing and migration is also discussed, as are microRNAs as new therapeutic targets. Finally, preclinical findings have shown that the neuroprotective benefits of these agents facilitate anti-inflammation, angiogenesis, neurogenesis, blood-brain barrier integrity, and disease-specific neuroprotection. These mechanisms can be compared with dysregulated disease mechanisms to suggest core cellular and molecular disturbances identifiable by specific risk biomarkers. Future clinical endeavors are warranted to determine the therapeutic potential of lithium and VPA across the spectrum of central nervous system diseases, with particular emphasis on a personalized medicine approach toward treating these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Psychotropic medicines may have an anti-inflammatory effect, signified by the fact that 1st episode mania group has a greater level of inflammation in comparison to bipolar mania.”
From Comparison of NLR (neutrophil/lymphocyte ratio) and PLR (platelet/lymphocyte ratio) as inflammatory markers in 1st episode mania and bipolar mania: A preliminary study (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lithium and valproate in bipolar disorder are thought to be partly responsible for therapeutic effects via their anti-inflammatory properties.”
From Comparison of NLR (neutrophil/lymphocyte ratio) and PLR (platelet/lymphocyte ratio) as inflammatory markers in 1st episode mania and bipolar mania: A preliminary study (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Different psychotropic medications may affect the inflammatory state via different mechanisms.[12,13]”
The cited source says what the claim attributes to it.
In the citing paper
“Lithium and valproate can affect microglial inactivation along with the reduction of overexposed proinflammatory cytokines, nitric oxide synthase, and COX-2.[12]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–580 of 580
Wang, J., Bown, C. D., & Young, L. T. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12177-3 · Cited by 96
Xu, C. D., Macciardi, F. M., Li, P. P., Yoon, I., Cooke, R. G., Hughes, B., Parikh, S. V., McIntyre, R. S., Kennedy, J. L., & Warsh, J. J. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30239 · Cited by 95
Chiang, M.-C., Chen, H.-M., Lee, Y.-H., Chang, H.-H., Wu, Y.-C., Soong, B.-W., Chen, C.-M., Wu, Y.-R., Liu, C.-S., Niu, D.-M., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl481 · Cited by 95
Marinova, Z., Leng, Y., Leeds, P. R., & Chuang, D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.022 · Cited by 93
Self-citationZádori, D., Geisz, A., Vámos, E., Vécsei, L., & Klivènyi, P. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.08.001 · Cited by 93
Tabolacci, E., Pietrobono, R., Moscato, U., Oostra, B. A., Chiurazzi, P., & Neri, G. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201393 · Cited by 92
Valproic Acid–induced Hepatopathy: Nine New Fatalities in Germany from 1994 to 2003
Koenig, S. A., Buesing, D., Longin, E., et al. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00846.x · Cited by 91
Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat
Schuettauf, F., Ręjdak, R., Thaler, S., et al. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.05.021 · Cited by 91
Zhang, Y., Sun, Y., Wang, F., Wang, Z., Peng, Y., & Li, R. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0724-2 · Cited by 91
Self-citationDash, P. K., Johnson, D., Clark, J. W., Orsi, S. A., Zhang, M., Zhao, J., Grill, R. J., Moore, A. N., & Pati, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024648 · Cited by 91
Michaelis, M., Suhan, T. O., Michaelis, U. R., Beek, K. V., Rothweiler, F., Tausch, L., Werz, O., Eikel, D., Zörnig, M., Nau, H., et al. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401759 · Cited by 91
Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin
Fass, D. M., Shah, R. R., Ghosh, B., Hennig, K. M., Norton, S., Zhao, W., Reis, S. A., Klein, P. S., Mazitschek, R., Maglathlin, R. L., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1001954 · Cited by 90
Regulation of glycogen synthase kinase‐3 during bipolar mania treatment
Li, X., Liu, M., 蔡卓基, Wang, G., & Li, X. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00866.x · Cited by 88
SMN1 gene, but not SMN2 , is a risk factor for sporadic ALS
Corcia, P., Camu, W., Halimi, J., Vourc’h, P., Antar, C., Védrine, S., Giraudeau, B., de Toffol, B., & Andres, C. R. (2006) · Neurology · doi:10.1212/01.wnl.0000233830.85206.1e · Cited by 87
A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium
Ferrucci, M., Spalloni, A., Bartalucci, A., Cantafora, E., Fulceri, F., Nutini, M., Longone, P., Paparelli, A., & Fornai, F. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.017 · Cited by 87
Lithium Upregulates Vascular Endothelial Growth Factor in Brain Endothelial Cells and Astrocytes
Guo, S., Arai, K., Stins, M. F., Chuang, D., & Lo, E. H. (2008) · Stroke · doi:10.1161/strokeaha.108.524504 · Cited by 86
Self-citationTherapeutic Angiogenesis for Brain Ischemia: A Brief Review
Fan, Y., & Yang, G. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9073-3 · Cited by 86
Risk of Aplastic Anemia in Patients Using Antiepileptic Drugs
Handoko, K. B., Souverein, P. C., van Staa, T. P., et al. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00596.x · Cited by 86
Improvement of Huntington's Disease with Olanzapine and Valproate
Grove, V. E., Quintanilla, J., & DeVaney, G. T. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431316 · Cited by 85
Shao, L., Sun, X., Xu, L., Young, L. T., & Wang, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.007 · Cited by 85
Cimarosti, H. I., Rodnight, R., Tavares, A. C., et al. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02310-2 · Cited by 83
Gill, A., Kidd, J. D., Vieira, F. G., Thompson, K., & Perrin, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006489 · Cited by 83
Bianchi, P., Ciani, E., Contestabile, A., Guidi, S., & Bartesaghi, R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00246.x · Cited by 82
Forester, B. P., Streeter, C. C., Berlow, Y. A., Tian, H., Wardrop, M., Finn, C. T., Harper, D. G., Renshaw, P. F., & Moore, C. M. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318172b3d0 · Cited by 82
de Castro, A. A., Ghisoni, K., Latini, A., Quevedo, J., Tasca, C. I., & Prediger, R. D. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.016 · Cited by 82
Valproic acid‐mediated Hsp70 induction and anti‐apoptotic neuroprotection in SH‐SY5Y cells
Pan, T., Li, X., Xie, W., Jankovic, J. J., & Le, W. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.067 · Cited by 81
Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice
Zhu, Z., Wang, Q., Han, B.-J., & William, C. P. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.07.008 · Cited by 81
Nakao, N., Brundin, P., Funa, K., Lindvall, O., & Odin, P. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(96)83489-4 · Cited by 80
Valproic acid-associated weight gain in older children and teens with epilepsy
Wirrell, E. C. (2003) · Pediatric Neurology · doi:10.1016/s0887-8994(02)00505-2 · Cited by 80
Hayashi, A., Kasahara, T., Kametani, M., Toyota, T., Yoshikawa, T., & Kato, T. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009358 · Cited by 80
Neuroprotective Mechanisms of Lithium in Murine Human Immunodeficiency Virus-1 Encephalitis
Dou, H., Ellison, B., Bradley, J., Kasyanov, A. M., Poluektova, L. Y., Xiong, H., Maggirwar, S. B., Dewhurst, S., Gelbard, H. A., & Gendelman, H. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2164-05.2005 · Cited by 79
KIAA0369, doublecortin-like kinase, is expressed during brain development
Burgess, H. A., Martı́nez, S., & Reiner, O. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4 · Cited by 79
Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury
Penas, C., Verdú, E., Asensio-Pinilla, E., Guzmán-Lenis, M.-S., Herrando‐Grabulosa, M., Navarro, X., & Casas, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.012 · Cited by 79
Kumar, A., Zloza, A., Moon, R. T., Watts, J., Tenorio, A. R., & Al‐Harthi, L. (2008) · Journal of Virology · doi:10.1128/jvi.02498-07 · Cited by 78
Koenig, S. A., Gerstner, T. A., Keller, A., et al. (2008) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3282f3f9ec · Cited by 78
Yang, W., Leystra‐Lantz, C., & Strong, M. J. (2008) · Brain Research · doi:10.1016/j.brainres.2007.12.031 · Cited by 78
Roh, M., Eom, T.-Y., Zmijewska, A. A., Sarno, P. D., Roth, K. A., & Jope, R. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.039 · Cited by 78
Verstraete, E., Veldink, J. H., Huisman, M. H. B., Draak, T., Uijtendaal, E. V., van der Kooi, A. J., Schelhaas, H. J., de Visser, M., van der Tweel, I., & van den Berg, L. H. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-302021 · Cited by 78
Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia.
Hunsberger, J. G., Fessler, E. B., Wang, Z., ELKAHLOUN, A. G., & Chuang, D. (2012) · Europe PMC (PubMed Central) · Cited by 77
Self-citationLv, L., Sun, Y., Han, X., Xu, C., Tang, Y., & Dong, Q. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.040 · Cited by 77
Tsai, L., Leng, Y., Wang, Z., Leeds, P. R., & Chuang, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.97 · Cited by 77
Self-citationSovner, R. (1989) · PubMed · Cited by 77
Hough, C. J., Lu, S., Davis, C. L., et al. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00308-4 · Cited by 76
Wood, N. I., & Morton, A. J. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00141-2 · Cited by 76
Hashimoto, R., Fujimaki, K., Jeong, M. R., et al. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00167-4 · Cited by 76
Multiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimers Disease
Huang, H., & Klein, P. S. (2006) · Current Drug Targets · doi:10.2174/1389450110607011389 · Cited by 76
Gould, T. D., O’Donnell, K. C., Picchini, A. M., Dow, E. R., Chen, G., & Manji, H. K. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.028 · Cited by 74
Chronic lithium treatment magnifies learning in rats
Nocjar, C., Hammonds, M. D., & Shim, S. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.063 · Cited by 74
Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils
Bian, Q., Shi, T., Chuang, D., & Qian, Y. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.054 · Cited by 74
Self-citationShin, J. H., Cho, S. I., Lim, H. R., Lee, J. K., Lee, Y. A., Noh, J. S., Joo, I. S., Kim, K.-W., & Gwag, B. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030676 · Cited by 74
Acetylcholinesterase-amyloid-β-peptide interaction and Wnt signaling involvement in Aβ neurotoxicity
Inestrosa, N. C., Alvarez, A. R., Godoy, J. A., et al. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00308.x · Cited by 72
Tau Phosphorylation and Cleavage in Ethanol-Induced Neurodegeneration in the Developing Mouse Brain
Saito, M., Chakraborty, G., Mao, R.-F., Paik, S.-M., Vadász, C., & Saito, M. (2010) · Neurochemical Research · doi:10.1007/s11064-009-0116-4 · Cited by 72
Genton, P., Semah, F., & Trinka, E. (2006) · Drug Safety · doi:10.2165/00002018-200629010-00001 · Cited by 72
Regulation of Neurogenesis and Angiogenesis in Depression
Newton, S. S., & Duman, R. S. (2004) · Current Neurovascular Research · doi:10.2174/1567202043362388 · Cited by 72
Pardo, R., Andreolotti, A. G., Ramos, B., Picatoste, F., & Claro, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02015.x · Cited by 71
Turner, B. J., Parkinson, N., Davies, K. E., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.005 · Cited by 71
Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys
Torrioli, M., Vernacotola, S., Setini, C., Bevilacqua, F., Martinelli, D., Snape, M., Hutchison, J. A., Di Raimo, F. R., Tabolacci, E., & Neri, G. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33484 · Cited by 71
Comparative analysis of the effects of four mood stabilizers in SH‐SY5Y cells and in primary neurons
Daniel, E. D., Mudge, A. W., & Maycox, P. R. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00164.x · Cited by 71
Miller, R. G., Moore, D. H., Forshew, D. A., Katz, J. S., Barohn, R. J., Valan, M., Bromberg, M. B., Goslin, K. L., Graves, M. C., McCluskey, L. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822dc7a5 · Cited by 70
Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway
Berger, Z., Ttofi, E. K., Michel, C. H., Pasco, M. Y., Tenant, S., Rubinsztein, D. C., & O’Kane, C. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi331 · Cited by 70
Ghribi, O., Herman, M. M., & Savory, J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10511 · Cited by 69
Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro
Lv, L., Han, X. H., Sun, Y., Wang, X., & Dong, Q. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.042 · Cited by 68
Kirshenboim, N., Plotkin, B., Shlomo, S. B., Kaidanovich‐Beilin, O., & Eldar-Finkelman, H. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:237 · Cited by 68
Ma, J., & Zhang, G. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00784-5 · Cited by 68
Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome
Mines, M. A., & Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00035 · Cited by 68
Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord
Calderó, J., Brunet, N., Tarabal, O., Piedrafita, L., Hereu, M., Ayala, V., & Esquerda, J. E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.034 · Cited by 67
Kim, Y., Rane, A., Lussier, S. J., & Andersen, J. K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22700 · Cited by 67
Huachun, S., Lu, Z., Li, Y., Ru, B., Wang, W., & Chen, J. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02206-6 · Cited by 67
Lithium protects ethanol-induced neuronal apoptosis.
Zhong, J., Yang, X.-L., Yao, W., & Lee, W. (2006) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2006.09.138 · Cited by 66
Liu, Z., Huang, T., & Smith, C. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.037 · Cited by 66
Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ ( POLG1 )
McFarland, R., Hudson, G., Taylor, R. W., Green, S. H., Hodges, S., McKiernan, P. J., Chinnery, P. F., & Ramesh, V. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.122911 · Cited by 65
Linking Alterations in Tau Phosphorylation and Cleavage during Neuronal Apoptosis
Rametti‐Lacroux, A., Esclaire, F., Yardin, C., & Terro, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408186200 · Cited by 64
Saft, C., Lauter, T., Kraus, P. H., et al. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-11 · Cited by 63
Age-dependent cognitive impairment in a Drosophila Fragile X model and its pharmacological rescue
Choi, C. H., McBride, S. M. J., Schoenfeld, B. P., Liebelt, D. A., Ferreiro, D., Ferrick, N. J., Hinchey, P., Kollaros, M., Ascunce, R. R., Terlizzi, A. M., et al. (2009) · Biogerontology · doi:10.1007/s10522-009-9259-6 · Cited by 63
Nuutinen, T., Suuronen, T., Kauppinen, A., & Salminen, A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.041 · Cited by 63
Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder
Perova, T., Wasserman, M. J., Li, P. P., & Warsh, J. J. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007973 · Cited by 63
Martin, L., Magnaudeix, A., Esclaire, F., Yardin, C., & Terro, F. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.057 · Cited by 62
Biermann, J., Boyle, J., Pielen, A., & Lagrèze, W. A. (2011) · PubMed Central · Cited by 62
A Double Blind Trial of Lithium Carbonate and Haloperidol in Huntington's Chorea
Leonard, D., Kidson, M. A., Brown, J. G. E., et al. (1975) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048677509159834 · Cited by 62
Hájek, T., Bauer, M., Pfennig, A., Cullis, J., Ploch, J., O’Donovan, C., Böhner, G., Klingebiel, R., Young, L. T., MacQUEEN, G. M., et al. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110097 · Cited by 62
The lithiumeter: a measured approach
Malhi, G. S., Tanious, M., & Gershon, S. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00918.x · Cited by 61
TRPM2 variants and bipolar disorder risk: confirmation in a family‐based association study
Xu, C. D., Li, P. P., Cooke, R. G., Parikh, S. V., Wang, K.-S., Kennedy, J. L., & Warsh, J. J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00655.x · Cited by 61
Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7
Rochette, C., Surh, L. C., Ray, P. N., et al. (1997) · Neurogenetics · doi:10.1007/s100480050021 · Cited by 60
Mood-Stabilizers Target the Brain Arachidonic Acid Cascade
Rao, J. S., & Rapoport, S. I. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902020207 · Cited by 60
Drug treatment for mood disorders in pregnancy
Gentile, S. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283413451 · Cited by 60
SMN1 gene duplications are associated with sporadic ALS
Blauw, H. M., Barnes, C. P., van Vught, P. W. J., van Rheenen, W., Verheul, M., Cuppen, E. P. J. G., Veldink, J. H., & van den Berg, L. H. (2012) · Neurology · doi:10.1212/wnl.0b013e318249f697 · Cited by 60
Bown, C. D., Wang, J., & Young, L. T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00029-0 · Cited by 60
Zhang, Z., Qin, X., Zhao, X., et al. (2012) · Current Eye Research · doi:10.3109/02713683.2011.653616 · Cited by 60
Hu, J.-P., Xie, J., Wang, C., Wang, T., Wang, X., Wang, S., Teng, W., & Wang, Z. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.03.006 · Cited by 60
Self-citationEstablishing a standardized therapeutic testing protocol for spinal muscular atrophy
Tsai, L., Tsai, M., Lin, T.-B., Hwu, W., & Li, H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.004 · Cited by 59
Serum Brain-Derived Neurotrophic Factor in Euthymic Bipolar Patients on Prophylactic Lithium Therapy
Suwalska, A., Sobieska, M., & RYBAKOWSKI, J. K. (2010) · Neuropsychobiology · doi:10.1159/000319949 · Cited by 58
Lithium in pregnancy: the need to treat, the duty to ensure safety
Gentile, S. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.670419 · Cited by 58
Effect of oxidative stress on TRPM2 and TRPC3 channels in B lymphoblast cells in bipolar disorder
Roedding, A. S., Gao, A. F., Au‐Yeung, W., Scarcelli, T., Li, P. P., & Warsh, J. J. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01003.x · Cited by 57
Genetic Mapping of a Mouse Modifier Gene That Can Prevent ALS Onset
Kunst, C. B., Messer, L. H., Gordon, J. W., Haines, J. L., & Patterson, D. (2000) · Genomics · doi:10.1006/geno.2000.6379 · Cited by 57
Wang, Z.-F., Fessler, E. B., & Chuang, D. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.140 · Cited by 57
Self-citationKarege, F., Perroud, N. A., Burkhardt, S., Fernandez, R. J., Ballmann, E., Harpe, R. L., & Malafosse, A. (2011) · Neuropsychobiology · doi:10.1159/000322145 · Cited by 57
Gül, H., Marquez‐Curtis, L. A., Jahroudi, N., Lo, J., Turner, A. R., & Janowska‐Wieczorek, A. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0235 · Cited by 57
Overexpression of glycogen synthase kinase 3β sensitizes neuronal cells to ethanol toxicity
Liu, Y., Chen, G., Ma, C., Bower, K. A., Xu, M., Fan, Z., Shi, X., Ke, Z., & Luo, J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22098 · Cited by 56
Muñoz-Montaño, J. R., Lim, F., Moreno, F. J., Ávila, J., & Díaz‐Nido, J. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-1602 · Cited by 55
Valproic acid enhances microglial phagocytosis of amyloid-β1–42
Smith, A. M., Gibbons, H. M., & Dragunow, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.041 · Cited by 54
Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero
Bromley, R., Baker, G. A., & Meador, K. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283292401 · Cited by 54
Rowland, L. P. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199408000-00006 · Cited by 53
Hunsberger, J. G., Austin, D. R., Chen, G., & Manji, H. K. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.103 · Cited by 52
Self-citationGene therapy for severe combined immune deficiency
Qasim, W., Gaspar, H. B., & Thrasher, A. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404007884 · Cited by 52
Lithium-mediated protection against ethanol neurotoxicity
Luo, J. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00041 · Cited by 51
Omata, N., Chiu, C., Moya, P. R., Leng, Y., Wang, Z., Hunsberger, J. G., Leeds, P. R., & Chuang, D. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000726 · Cited by 51
Self-citationProfenno, L. A., Jakimovich, L. J., Holt, C. J., Porsteinsson, A. P., & Tariot, P. N. (2005) · Current Alzheimer Research · doi:10.2174/156720505774932205 · Cited by 50
Lithium pretreatment reduces brain injury after intracerebral hemorrhage in rats
Kang, K., Kim, Y., Kim, Y., Roh, J.-K., Nam, J.-M., Kim, P.-Y., Ryu, W.-S., Lee, S.-H., & Bw, Y. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000015 · Cited by 48
TREATMENT OF HUNTINGTON'S CHOREA WITH LITHIUM CARBONATE A Double-blind Trial
Aminoff, M. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92339-3 · Cited by 48
HUNTINGTON'S CHOREA AND LITHIUM THERAPY
Mattsson, B. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91500-6 · Cited by 46
Crochemore, C., Virgili, M., Bonamassa, B., Canistro, D., Peña‐Altamira, E., Paolini, M., & Contestabile, A. (2009) · Muscle & Nerve · doi:10.1002/mus.21260 · Cited by 46
BACLOFEN AND LITHIUM IN HUNTINGTON'S CHOREA
Andén, N., Dalén, P., & Johansson, B. B. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93285-6 · Cited by 46
Maler, J. M., Spitzer, P., Lewczuk, P., Kornhuber, J., i, M. H., & Wiltfang, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001913 · Cited by 45
Lithium down-regulates tau in cultured cortical neurons: A possible mechanism of neuroprotection
Rametti‐Lacroux, A., Esclaire, F., Yardin, C., Cogné, N., & Terro, F. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.01.034 · Cited by 45
Valproic Acid Induces Monoamine Oxidase A via Akt/Forkhead Box O1 Activation
Wu, B. J., & Shih, J. C. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072744 · Cited by 45
Hormonal and reproductive disturbances in epileptic male patients: Emerging issues
Verrotti, A., Loiacono, G., Laus, M., Coppola, G., Chiarelli, F., & Tiboni, G. M. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.02.002 · Cited by 44
Restoring Bcl-xL levels benefits a mouse model of spinal muscular atrophy
Tsai, L., Tsai, M., Ting, C.-H., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.014 · Cited by 44
Tabolacci, E., De Pascalis, I., Accadia, M., Terracciano, A., Moscato, U., Chiurazzi, P., & Neri, G. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830500a1 · Cited by 44
Functional MRI of Delayed Chronic Lithium Treatment in Rat Focal Cerebral Ischemia
Kim, Y. R., van Meer, M. P. A., Tejima, E., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.492215 · Cited by 43
Kalasapudi, V. D., Sheftel, G., Divish, M. M., et al. (1990) · Brain Research · doi:10.1016/0006-8993(90)91523-j · Cited by 42
Serdaroğlu, G., Tütüncüoğlu, S., Kavaklı, K., et al. (2002) · Journal of Child Neurology · doi:10.1177/088307380201700110 · Cited by 42
Andreopoulos, S., Wasserman, M., Woo, K., Li, P. P., & Warsh, J. J. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500266 · Cited by 42
Gupta, A. K., Schulze, T. G., Nagarajan, V., Akula, N., Corona, W., Jiang, X.-Y., Hunter, N., McMahon, F. J., & Detera-Wadleigh, S. D. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.9 · Cited by 42
Omata, N., Murata, T., Takamatsu, S., Maruoka, N., Mitsuya, H., Yonekura, Y., Fujibayashi, Y., & Wada, Y. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00521.x · Cited by 41
GRP78 counteracts cell death and protein aggregation caused by mutant huntingtin proteins
Jiang, Y., Lv, H., Liao, M., Xu, X., Huang, S., Tan, H., Peng, T., Zhang, Y., & He, L. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.074 · Cited by 41
Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro
Jin, G., Bausch, D., Knightly, T., Liu, Z., Li, Y., Liu, B., Lu, J., Chong, W., Velmahos, G. C., & Alam, H. B. (2011) · Surgery · doi:10.1016/j.surg.2011.07.001 · Cited by 41
French, R. L., & Heberlein, U. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910813106 · Cited by 41
Lithium prevents stress-induced reduction of vascular endothelium growth factor levels
Silva, R. F., Martins, L., Longatto‐Filho, A., Almeida, O. F. X., & Sousa, N. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.062 · Cited by 40
Posttraumatic stress disorder and traumatic stress: from bench to bedside, from war to disaster
Ursano, R. J., Goldenberg, M., Zhang, L., Carlton, J. R., Fullerton, C. S., Li, H., Johnson, L. R., & Benedek, D. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05721.x · Cited by 39
Post-mortem high affinity glutamate uptake in human brain
Schwarcz, R. M., & Whetsell, W. O. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90034-3 · Cited by 39
Luo, G. Y., & Le, W. D. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790909740 · Cited by 39
Neuroprotection by Valproic Acid in Mouse Models of Permanent and Transient Focal Cerebral Ischemia
Qian, Y. R., Lee, M.-J., Hwang, S., Kook, J. H., Kim, J.-K., & Bae, C. S. (2010) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2010.14.6.435 · Cited by 39
Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment
Huang, W., Galdzicki, Z., van Gelderen, P., Balbo, A., Chikhale, E. G., Schapiro, M. B., & Rapoport, S. I. (2000) · Neuroreport · doi:10.1097/00001756-200002280-00004 · Cited by 38
Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions
Koh, S., Yoo, A., Chang, D., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.006 · Cited by 38
Crespo‐Biel, N., Camins, A., Pallàs, M., & Canudas, A. M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.012 · Cited by 38
Harahap, I. S. K., Saito, T., San, L. P., Sasaki, N., Gunadi, G., Nurputra, D. K., Yusoff, S., Yamamoto, T., Morikawa, S., Nishimura, N., et al. (2011) · Brain and Development · doi:10.1016/j.braindev.2011.04.010 · Cited by 38
MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field
Dinan, T. G. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990800 · Cited by 38
Yick, L.-W., So, K., Cheung, P., et al. (2004) · Journal of Neurotrauma · doi:10.1089/neu.2004.21.932 · Cited by 37
Walasek, M. A., Bystrykh, L. V., van den Boom, V., Olthof, S. G. M., Ausema, A., Ritsema, M., Huls, G. A., de Haan, G., & van Os, R. P. (2012) · Blood · doi:10.1182/blood-2011-08-375386 · Cited by 36
Grosso, S., Mostardini, R., Piccini, B., et al. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l414 · Cited by 36
Sodium valproate in Huntington's disease
Symington, G. R., Leonard, D., Shannon, P. J., et al. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.3.352 · Cited by 34
Use of Lithium in the Treatment of Bipolar Disorder in Late-Life
D’Souza, R., Rajji, T. K., Mulsant, B. H., & Pollock, B. G. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0228-9 · Cited by 33
Effect of Valproic Acid Through Regulation of NMDA Receptor–ERK Signaling in Sleep Deprivation Rats
Park, H. J., Kang, W. S., Paik, J., & Kim, J. W. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9673-5 · Cited by 33
The importance of theSMNgenes in the genetics of sporadic ALS
Corcia, P., Camu, W., Praline, J., Gordon, P. H., Vourc’h, P., & Andres, C. R. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902759162 · Cited by 33
Promoting Optic Nerve Regeneration in Adult Mice with Pharmaceutical Approach
Cho, K., & Chen, D. F. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9736-3 · Cited by 32
Liang, Z.-Q., Wang, X., Wang, Y.-M., Chuang, D. M., DiFiglia, M., Chase, T., & Qin, Z.-H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.011 · Cited by 31
Self-citationIntrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy
Shimizu, T., Shibata, M., Wakisaka, S., Inoue, T., Mashimo, T., & Yoshiya, I. (2000) · Pain · doi:10.1016/s0304-3959(99)00249-3 · Cited by 31
Lithium treatment of Huntington's chorea
Vestergaard, P., Baastrup, P. C., & Petersson, H. (1977) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1977.tb03561.x · Cited by 30
LITHIUM CARBONATE IN HUNTINGTON'S CHOREA
Manyam, N. V. B., & Bravo-Fernández, E. F. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91664-4 · Cited by 29
DOUBLE-BLIND TRIAL OF LITHIUM CARBONATE AND HALOPERIDOL IN HUNTINGTON'S CHOREA
Leonard, D., Kidson, M. A., Shannon, P. J., et al. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90847-2 · Cited by 29
Gao, X., Fukamauchi, F., & Chuang, D. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90021-v · Cited by 28
Self-citationLithium blocks ethanol-induced modulation of protein kinases in the developing brain
Chakraborty, G., Saito, M., Mao, R., Wang, R., Vadász, C., & Saito, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.004 · Cited by 28
Liang, Z., Wang, X., Li, L., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21248 · Cited by 27
Identification of mood stabilizer-regulated genes by differential-display PCR
Wang, J., Bown, C. D., Chen, B., et al. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002231 · Cited by 27
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population
Corcia, P., Ingre, C., Blasco, H., Press, R., Praline, J., Antar, C., Veyrat‐Durebex, C., Guettard, Y.-O., Camu, W., Andersen, P. M., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.255 · Cited by 26
Lithium and oxidative stress lessons from the MPTP model of Parkinson's disease
Arraf, Z., Amit, T., Youdim, M. B. H., & Farah, R. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.055 · Cited by 25
Ishii, T., Hashimoto, E., Ukai, W., Tateno, M., Yoshinaga, T., Saitô, S., Sohma, H., & Saito, T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.021 · Cited by 24
Aoki, T., Koike, T., Nakano, T., et al. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021554 · Cited by 23
HUNTINGTON'S CHOREA TREATED WITH LITHIUM CARBONATE
Carman, J., Shoulson, I., & Chase, T. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92881-5 · Cited by 22
Combination therapies for traumatic brain injury: prospective considerations
Margulies, S. S., & Hicks, R. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008-0794 · Cited by 22
The mood stabilizer valproic acid induces proliferation and myelination of rat Schwann cells
Wu, F., Yu, A., Danmou, X., et al. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.04.002 · Cited by 22
HUNTINGTON'S CHOREA AND LEVODOPA
Schenk, G., & Leijnse-Ybema, H. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93130-4 · Cited by 21
Involvement of c-Fos in signaling grp78 induction following ER calcium release
He, H., McColl, K. S., & Distelhorst, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203994 · Cited by 21
Brinkman, S. D., Pomara, N., Barnett, N., et al. (1984) · PubMed · Cited by 21
Tsuji, S., Morinobu, S., Tanaka, K., Kawano, K.-I., & Yamawaki, S. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0798-0 · Cited by 20
Low-Dose Divalproex in Agitated Patients with Alzheimer's Disease
Dolder, C. R., & McKinsey, J. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000367781.26507.86 · Cited by 20
Lithium treatment attenuates muscarinic M1 receptor dysfunction
Creson, T. K., Austin, D. R., Shaltiel, G., McCammon, J., Wess, J., Manji, H. K., & Chen, G. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00915.x · Cited by 20
Zhuang, J., Fan, L., Liu, X., Liu, Z., Lin, J., Ge, Y., Kaminski, J., Summers, J. B., Wang, Z., Ge, J., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.162 · Cited by 20
Self-citationTreatment of Huntington's chorea with bal.
Jm, N., & BUTT, E. M. (1955) · PubMed · Cited by 18
A new prize system for drug innovation
Gandjour, A., & Chernyak, N. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.06.001 · Cited by 17
Autophagy activation in glutamate-induced motor neuron loss.
Fulceri, F., Ferrucci, M., Lazzeri, G., Paparelli, S., Bartalucci, A., Tamburini, I., Paparelli, A., & Fornai, F. (2011) · PubMed · doi:10.4449/aib.v149i1.1259 · Cited by 16
The necessity for a collection development policy statement.
Feng, Y. T. (1979) · PubMed · Cited by 15
Juvenile Absence Epilepsy Exacerbated by Valproic Acid
Buechler, R. D., & Buchhalter, J. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2006.08.011 · Cited by 15
Varoğlu, A. O. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.06.009 · Cited by 9
Sodium valproate in huntington's chorea
Tan, B. K., Leijnse-Ybema, H. J., & Zee, M. F. H. (1976) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(76)80007-8 · Cited by 8
Huntington’s disease and HDACi: Would sulpiride and valproate be of therapeutic value?
Tremolizzo, L., Rodriguez‐Menendez, V., DiFrancesco, J. C., et al. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.02.025 · Cited by 6
[Lithium therapy of extrapyramidal movement disorders-an attempt (author's transl)].
Foerster, K., & Regli, F. (1977) · PubMed · Cited by 6
Lithium treatment in amyotrophic lateral sclerosis: do we have enough trials?
de Carvalho, M. A., & Pinto, S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.164 · Cited by 3
(1824) · The Lancet · doi:10.1016/s0140-6736(02)95569-8 · Cited by 2
Miller (1999) · doi:10.1002/(sici)1096-8628(19990402)83:4
Flagged first, then by citations
Research works printed but not linked: 1
- Senatorov, 2007, Lithium protects against quinolinic-acid excitotoxicity in rat cortico-striatal organotypic culture, Int J Neuroprotect Neuroregen, 3, 122
Cited by
Sorted by citations
Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia
Berridge, M. J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1806-z · Cited by 181
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Varela, R. B., Valvassori, S. S., Lopes-Borges, J., Mariot, E., Dal-Pont, G. C., Amboni, R. T., Bianchini, G., & Quevedo, J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.11.003 · Cited by 115
Mechanism of microglia neuroprotection: Involvement of P2X 7,TNF α, and valproic acid
Masuch, A., Shieh, C., van Rooijen, N., van Calker, D., & Biber, K. (2016) · Glia · doi:10.1002/glia.22904 · Cited by 81
Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder
Pfaffenseller, B., Fries, G. R., Wollenhaupt-Aguiar, B., Colpo, G. D., Stertz, L., Panizzutti, B., Magalhães, P. V., & Kapczinski, F. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811981 · Cited by 68
Metadata
- Authors
- Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M.
- Affiliations
- National Institutes of Health (US)
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 105-142
- ISSN
- 0031-6997 (ISSN-L)
- PMC
- PMC3565922
- OpenAlex
- W2098378665
- Semantic Scholar
- 6456393e5aa0c08efe167d1c5f7431d6ee18dae1
- Cited by
- 404
- References
- 580
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 14 · 2023: 20 · 2022: 19 · 2021: 39 · 2020: 31 · 2019: 29 · 2018: 27 · 2017: 33 · 2016: 53 · 2015: 42 · 2014: 45 · 2013: 13
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Pharmacological Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- lithium, valproic acid, mood stabilizers, bipolar disorder, glycogen synthase kinase-3, histone deacetylase, neuroprotection, neurotrophic factors, angiogenesis, oxidative stress, protein quality control, stem cell homing, microRNA, neuroinflammation, blood-brain barrier, neurogenesis, anti-inflammation, personalized medicine, risk biomarkers, neurodegenerative diseases, neuropsychiatric disorders
- MeSH terms
- Animals, Bipolar Disorder, Central Nervous System Diseases, Humans, Valproic Acid, Lithium Compounds, Antimanic Agents, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review